136 related articles for article (PubMed ID: 3447935)
21. Pharmacokinetics of [14C]ciclesonide after oral and intravenous administration to healthy subjects.
Nave R; Bethke TD; van Marle SP; Zech K
Clin Pharmacokinet; 2004; 43(7):479-86. PubMed ID: 15139796
[TBL] [Abstract][Full Text] [Related]
22. Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat.
Schoenig GP; Hartnagel RE; Osimitz TG; Llanso S
Drug Metab Dispos; 1996 Feb; 24(2):156-63. PubMed ID: 8742226
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics of ethylene glycol. III. Plasma disposition and metabolic fate after single increasing intravenous, peroral, or percutaneous doses in the male Sprague-Dawley rat.
Frantz SW; Beskitt JL; Tallant MJ; Zourelias LA; Ballantyne B
Xenobiotica; 1996 May; 26(5):515-39. PubMed ID: 8736063
[TBL] [Abstract][Full Text] [Related]
24. A clinically relevant review of tizanidine hydrochloride dose relationships to pharmacokinetics, drug safety and effectiveness in healthy subjects and patients.
Henney HR; Runyan JD
Int J Clin Pract; 2008 Feb; 62(2):314-24. PubMed ID: 18199279
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics and metabolism of single oral doses of trovafloxacin.
Vincent J; Teng R; Dalvie DK; Friedman HL
Am J Surg; 1998 Dec; 176(6A Suppl):8S-13S. PubMed ID: 9935250
[TBL] [Abstract][Full Text] [Related]
26. The disposition of radioactivity after administration of the anthelminthic methyl-14C-5-cyclopropylcarbonyl-2-benzimidazole carbamate (ciclobendazole) to rats and dogs.
Brodie RR; Mayo BC; Chasseaud LF; Hawkins DR
Arzneimittelforschung; 1977; 27(3):593-8. PubMed ID: 577426
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics of 14C-delmopinol in the healthy male volunteer.
Eriksson B; Ottersgård Brorsson AK; Hallström G; Sjödin T; Gunnarsson PO
Xenobiotica; 1998 Nov; 28(11):1075-81. PubMed ID: 9879639
[TBL] [Abstract][Full Text] [Related]
28. Disposition and pharmacokinetics of [14C]finasteride after oral administration in humans.
Carlin JR; Höglund P; Eriksson LO; Christofalo P; Gregoire SL; Taylor AM; Andersson KE
Drug Metab Dispos; 1992; 20(2):148-55. PubMed ID: 1352203
[TBL] [Abstract][Full Text] [Related]
29. Orally active inhibitors of human leukocyte elastase. I. Disposition of L-683,845 in rats and rhesus monkeys.
Vincent SH; Painter SK; Krieter PA; Colletti AE; Lyszack E; Rosegay A; Dean D; Luffer-Atlas D; Miller RR; Cioffe C; Chiu SH
Drug Metab Dispos; 1996 Dec; 24(12):1369-77. PubMed ID: 8971144
[TBL] [Abstract][Full Text] [Related]
30. Relative bioavailability of tizanidine hydrochloride capsule formulation compared with capsule contents administered in applesauce: a single-dose, open-label, randomized, two-way, crossover study in fasted healthy adult subjects.
Henney HR; Fitzpatrick A; Stewart J; Runyan JD
Clin Ther; 2008 Dec; 30(12):2263-71. PubMed ID: 19167586
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetics and metabolism of tesaglitazar, a novel dual-acting peroxisome proliferator-activated receptor alpha/gamma agonist, after a single oral and intravenous dose in humans.
Ericsson H; Hamrén B; Bergstrand S; Elebring M; Fryklund L; Heijer M; Ohman KP
Drug Metab Dispos; 2004 Sep; 32(9):923-9. PubMed ID: 15319332
[TBL] [Abstract][Full Text] [Related]
32. A severe interaction between Tizanidine and Ciprofloxacin.
Abd-Elsayed A; Elsharkawy H; Sakr W
J Clin Anesth; 2015 Dec; 27(8):698. PubMed ID: 26138629
[No Abstract] [Full Text] [Related]
33. Distribution and elimination of RGH-5002 in rats.
Terjéki E; Pátfalusi M; Trafikánt G; Kapás M
Acta Physiol Hung; 1995; 83(2):143-50. PubMed ID: 8588501
[TBL] [Abstract][Full Text] [Related]
34. Rifampicin is only a weak inducer of CYP1A2-mediated presystemic and systemic metabolism: studies with tizanidine and caffeine.
Backman JT; Granfors MT; Neuvonen PJ
Eur J Clin Pharmacol; 2006 Jun; 62(6):451-61. PubMed ID: 16758262
[TBL] [Abstract][Full Text] [Related]
35. Tizanidine--initial pharmacokinetic studies in patients with spasticity.
Heazlewood V; Symoniw P; Maruff P; Eadie MJ
Eur J Clin Pharmacol; 1983; 25(1):65-7. PubMed ID: 6617726
[TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetic comparison of two 4 mg tablet formulations of tizanidine.
Al-Ghazawi M; Alzoubi M; Faidi B
Int J Clin Pharmacol Ther; 2013 Mar; 51(3):255-62. PubMed ID: 23380428
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics and metabolism of rosaramicin in humans.
Lin CC; Chung M; Gural R; Schuessler D; Kim HK; Radwanski E; Marco A; DiGiore C; Symchowicz S
Antimicrob Agents Chemother; 1984 Oct; 26(4):522-6. PubMed ID: 6517543
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics of NS-49, a phenethylamine class alpha 1A-adrenoceptor agonist. 4th communication: tissue distribution, placental transfer and milk secretion of radioactivity in rats after a single oral administration of 14C-NS-49, and effects of repeated administration on its pharmacokinetics.
Dalrymple PD; Beeby TL; Mukai H; Chasseaud LF
Arzneimittelforschung; 2001; 51(5):394-401. PubMed ID: 11413740
[TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics and metabolism of the 5-hydroxytryptamine antagonist tropisetron after single oral doses in humans.
Fischer V; Baldeck JP; Tse FL
Drug Metab Dispos; 1992; 20(4):603-7. PubMed ID: 1356742
[TBL] [Abstract][Full Text] [Related]
40. [Influence of a muscle relaxant, tizanidine, on gastric acid secretion and gastric ulcer in rats].
Watanabe K; Watanabe H; Maeda-Hagiwara M; Kanaoka R
Nihon Yakurigaku Zasshi; 1983 Oct; 82(4):237-45. PubMed ID: 6662417
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
